Swiss Federal Institute of Technology (ETH) Zurich spin-out Qvanteq raises CHF 4m ($4.3m).
Qvanteq, an ETH Zurich med-tech spin-out founded in 2009, has raised a CHF4m ($4.3m) in its series B round from private investors. Qvanteq plans to use the funds to obtains clinical proof of concept in a “First-in-Man” study. It also plans to acquire CE market approval for a coronary product. The firm said in a statement that it expected a straightforward approval process as surface technology developed by the firm overcomes problems associated with coating technologies.